Albemarle Corporation (LON:0HC7)
London · Delayed Price · Currency is GBP · Price in USD 160.81
-10.59 (-6.18%)
Feb 12, 2026, 5:08 PM GMT
Albemarle Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,143 | 5,378 | 9,617 | 7,320 | 3,328 | |
Revenue Growth (YoY) | -4.37% | -44.08% | 31.38% | 119.96% | 6.36% |
Cost of Revenue | 4,474 | 5,293 | 8,420 | 4,242 | 2,319 |
Gross Profit | 668.72 | 84.24 | 1,197 | 3,078 | 1,008 |
Selling, General & Admin | 550.04 | 595.27 | 644.07 | 439.14 | 333.31 |
Research & Development | 51.4 | 86.72 | 85.73 | 71.98 | 54.03 |
Operating Expenses | 601.43 | 681.99 | 729.8 | 511.12 | 387.34 |
Operating Income | 67.29 | -597.75 | 467.11 | 2,567 | 621.13 |
Interest Expense | -207.65 | -165.62 | -116.07 | -103.75 | -32.52 |
Interest & Investment Income | - | 36.3 | 19.3 | - | - |
Earnings From Equity Investments | 243.74 | 715.43 | 1,854 | 772.28 | 95.77 |
Currency Exchange Gain (Loss) | - | 67.5 | 39.9 | -21.8 | 0.1 |
Other Non Operating Income (Expenses) | 22.66 | 121.84 | 80.27 | 44.49 | 14.65 |
EBT Excluding Unusual Items | 126.04 | 177.71 | 2,345 | 3,258 | 699.14 |
Merger & Restructuring Charges | -7.7 | -1,187 | -38.56 | -20.56 | -15.87 |
Impairment of Goodwill | -181.07 | - | -6.77 | - | - |
Gain (Loss) on Sale of Investments | - | -72.86 | 31.96 | -4.08 | 295.97 |
Gain (Loss) on Sale of Assets | - | 40.9 | - | - | - |
Asset Writedown | -245.6 | - | - | - | - |
Legal Settlements | - | - | -233.61 | 0.1 | -667.91 |
Other Unusual Items | - | -7.2 | -4.1 | -27.62 | -81.94 |
Pretax Income | -308.33 | -1,048 | 2,101 | 3,206 | 229.39 |
Income Tax Expense | 156.88 | 87.09 | 430.28 | 390.59 | 29.45 |
Earnings From Continuing Operations | -465.21 | -1,135 | 1,671 | 2,815 | 199.94 |
Net Income to Company | -465.21 | -1,135 | 1,671 | 2,815 | 199.94 |
Minority Interest in Earnings | -45.42 | -43.97 | -97.07 | -125.32 | -76.27 |
Net Income | -510.63 | -1,179 | 1,573 | 2,690 | 123.67 |
Preferred Dividends & Other Adjustments | 166.75 | 136.65 | - | - | - |
Net Income to Common | -677.38 | -1,316 | 1,573 | 2,690 | 123.67 |
Net Income Growth | - | - | -41.50% | 2074.96% | -67.09% |
Shares Outstanding (Basic) | 118 | 118 | 117 | 117 | 116 |
Shares Outstanding (Diluted) | 118 | 118 | 118 | 118 | 117 |
Shares Change (YoY) | 0.13% | -0.21% | -0.02% | 1.08% | 9.11% |
EPS (Basic) | -5.76 | -11.20 | 13.41 | 22.97 | 1.07 |
EPS (Diluted) | -5.76 | -11.20 | 13.36 | 22.84 | 1.06 |
EPS Growth | - | - | -41.51% | 2054.72% | -69.89% |
Free Cash Flow | 692.47 | -983.72 | -823.96 | 646.2 | -609.41 |
Free Cash Flow Per Share | 5.88 | -8.37 | -7.00 | 5.49 | -5.23 |
Dividend Per Share | - | 1.610 | 1.600 | 1.580 | 1.560 |
Dividend Growth | - | 0.63% | 1.27% | 1.28% | 1.30% |
Gross Margin | 13.00% | 1.57% | 12.45% | 42.05% | 30.30% |
Operating Margin | 1.31% | -11.12% | 4.86% | 35.06% | 18.66% |
Profit Margin | -13.17% | -24.47% | 16.36% | 36.75% | 3.72% |
Free Cash Flow Margin | 13.46% | -18.29% | -8.57% | 8.83% | -18.31% |
EBITDA | 725.96 | -9.11 | 897.06 | 2,868 | 875.13 |
EBITDA Margin | 14.12% | -0.17% | 9.33% | 39.17% | 26.30% |
D&A For EBITDA | 658.68 | 588.64 | 429.94 | 300.84 | 254 |
EBIT | 67.29 | -597.75 | 467.11 | 2,567 | 621.13 |
EBIT Margin | 1.31% | -11.12% | 4.86% | 35.06% | 18.66% |
Effective Tax Rate | - | - | 20.48% | 12.18% | 12.84% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.